Vitamin b12 toxicity uptodate

Vitamin b12 toxicity uptodate DEFAULT

How I treat cobalamin (vitamin B12) deficiency

1. Chanarin I. 2nd ed. Oxford, United Kingdom: Blackwell Scientific; 1979. The Megaloblastic Anaemias. [Google Scholar]

2. Carmel R. Macrocytosis, mild anemia and delay in diagnosis of pernicious anemia. Arch Intern Med. 1979;139:47–50. [PubMed] [Google Scholar]

3. Carmel R. Pernicious anemia: the expected findings of very low serum cobalamin levels, anemia, and macrocytosis are often lacking. Arch Intern Med. 1988;148:1712–1714. [PubMed] [Google Scholar]

4. Healton EB, Savage DG, Brust JCM, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine. 1991;70:229–244. [PubMed] [Google Scholar]

5. Chan CWJ, Liu SYH, Kho CSB, et al. Diagnostic clues to megaloblastic anaemia without macrocytosis. Int J Lab Hematol. 2007;29:163–171. [PubMed] [Google Scholar]

6. Savage D, Lindenbaum J. Relapses after interruption of cyanocobalamin therapy in patients with pernicious anemia. Am J Med. 1983;74:765–772. [PubMed] [Google Scholar]

7. Magnus EM. Cobalamin and unsaturated transcobalamin values in pernicious anaemia: relation to treatment. Scand J Haematol. 1986;36:457–465. [PubMed] [Google Scholar]

8. Carmel R, Melnyk S, James SJ. Cobalamin deficiency with and without neurologic abnormalities: differences in homocysteine and methionine metabolism. Blood. 2003;101:3302–3308. [PubMed] [Google Scholar]

9. Carmel R. Cobalamin, the stomach, and aging. Am J Clin Nutr. 1997;66:750–759. [PubMed] [Google Scholar]

10. Lindenbaum J, Rosenberg IH, Wilson PWF, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr. 1994;60:2–11. [PubMed] [Google Scholar]

11. Carmel R, Green R, Jacobsen DW, Rasmussen K, Florea M, Azen C. Serum cobalamin, homocysteine and methylmalonic acid concentrations in a multiethnic elderly population: ethnic and sex differences in cobalamin and metabolite abnormalities. Am J Clin Nutr. 1999;70:904–910. [PubMed] [Google Scholar]

12. Moelby L, Nielsen G, Rasmussen K, Jensen MK, Pedersen KO. Metabolic cobalamin deficiency in patients with low to low-normal plasma cobalamin. Scand J Clin Lab Invest. 1997;57:209–216. [PubMed] [Google Scholar]

13. Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 2004;50:3–32. [PubMed] [Google Scholar]

14. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Diagnosis of cobalamin deficiency: usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol. 1990;34:90–98. [PubMed] [Google Scholar]

15. Tudhope GR, Swan HT, Spray GH. Patient variation in pernicious anaemia, as shown in a clinical trial of cyanocobalamin, hydroxocobalamin, and cyanocobalamin-zinc tannate. Br J Haematol. 1967;13:216–228. [PubMed] [Google Scholar]

16. Berlin H, Berlin R, Brante G. Oral treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor. Acta Med Scand. 1968;184:247–258. [PubMed] [Google Scholar]

17. Tordjman R, Genereau T, Guinnepain MT, et al. Reintroduction of vitamin B12 in 2 patients with prior B12-induced anaphylaxis. Eur J Haematol. 1998;60:269–270. [PubMed] [Google Scholar]

18. Caballero MR, Lukawaska J, Lee TH, Dugue P. Allergy to vitamin B12: two cases of successful desensitization with cyanocobalamin. Allergy. 2007;62:1341–1342. [PubMed] [Google Scholar]

19. Gimsing P, Hippe E, Helleberg-Rasmussen I, et al. Cobalamin forms in plasma and tissue during treatment of vitamin B12 deficiency. Scand J Haematol. 1982;29:311–318. [PubMed] [Google Scholar]

20. Carmel R, Shulman IA. Blood transfusion in medically treatable chronic anemia: pernicious anemia as a model for transfusion overuse. Arch Pathol Lab Med. 1989;113:995–997. [PubMed] [Google Scholar]

21. Lawson DH, Parker JLW. Deaths from severe megaloblastic anaemia in hospitalized patients. Scand J Haematol. 1976;17:347–352. [PubMed] [Google Scholar]

22. Carmel R. Treatment of severe PA: no association with sudden death. Am J Clin Nutr. 1988;48:1443–1444. [PubMed] [Google Scholar]

23. Carmel R, Weiner JM, Johnson CS. Iron deficiency occurs frequently in patients with pernicious anemia. JAMA. 1987;257:1081–1083. [PubMed] [Google Scholar]

24. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006;5:949–960. [PubMed] [Google Scholar]

25. Carmel R. Efficacy and safety of fortification and supplementation with vitamin B12: biochemical and physiologic effects. Food Nutr Bull. 2008;29(suppl):S177–S187. [PubMed] [Google Scholar]

26. Dietary Reference Intakes: Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy of Sciences; 1998. Panel on Folate, Other B Vitamins, and Choline; Institute of Medicine. Vitamin B12. pp. 306–356. [Google Scholar]

27. Carmel R. Malabsorption of food cobalamin. Baillieres Clin Haematol. 1995;8:639–655. [PubMed] [Google Scholar]

28. Cohen H, Weinstein WM, Carmel R. The heterogeneity of gastric histology and function in food cobalamin malabsorption: absence of atrophic gastritis and achlorhydria in some patients with severe malabsorption. Gut. 2000;47:638–645.[PMC free article] [PubMed] [Google Scholar]

29. Suter PM, Golner BB, Goldin BR, Morrow FD, Russell RM. Reversal of protein-bound vitamin B12 malabsorption with antibiotics in atrophic gastritis. Gastroenterology. 1991;101:1039–1045. [PubMed] [Google Scholar]

30. Carmel R, Mallidi P, Vinarskiy S, Brar S, Frouhar Z. Hyperhomocysteinemia and cobalamin deficiency in young Asian Indians in the United States. Am J Hematol. 2002;70:107–114. [PubMed] [Google Scholar]

31. Antony AC. Vegetarianism and vitamin B-12 (cobalamin) deficiency. Am J Clin Nutr. 2003;78:3–6. [PubMed] [Google Scholar]

32. Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med. 1994;96:239–246. [PubMed] [Google Scholar]

33. Doscherholmen A, Swaim WR. Impaired assimilation of egg Co57 vitamin B12 in patients with hypochlorhydria and achlorhydria and after gastric resection. Gastroenterology. 1973;64:913–919. [PubMed] [Google Scholar]

34. Carmel R. Nutritional vitamin B12 deficiency: possible contributory role of subtle vitamin B12 malabsorption. Ann Intern Med. 1978;88:647–649. [PubMed] [Google Scholar]

35. King CE, Leibach J, Toskes PP. Clinically significant vitamin B12 deficiency secondary to malabsorption of protein-bound vitamin B12. Dig Dis Sci. 1979;24:397–402. [PubMed] [Google Scholar]

36. Carmel R, Sinow RM, Karnaze DS. Atypical cobalamin deficiency: subtle biochemical evidence of deficiency is commonly demonstrable in patients without megaloblastic anemia and is often associated with protein-bound cobalamin malabsorption. J Lab Clin Med. 1987;109:454–463. [PubMed] [Google Scholar]

37. Carmel R. The disappearance of cobalamin absorption testing: a critical diagnostic loss. J Nutr. 2007;137:2481–2484. [PubMed] [Google Scholar]

38. Carmel R. Pepsinogens and other serum markers in pernicious anemia. Am J Clin Pathol. 1988;90:442–445. [PubMed] [Google Scholar]

39. Schilling RF, Gohdes PN, Hardie GH. Vitamin B12 deficiency after gastric bypass surgery for obesity. Ann Intern Med. 1984;101:501–502. [PubMed] [Google Scholar]

40. Rajan S, Wallace JI, Brodkin KI, Beresford SA, Allen RH, Stabler SP. Response of elevated methylmalonic acid to three dose levels of oral cobalamin in older adults. J Am Geriatr Soc. 2002;50:1789–1795. [PubMed] [Google Scholar]

41. Seal EC, Metz J, Flicker L, Melny J. A randomized, double-blind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations. J Am Geriatr Soc. 2002;50:146–151. [PubMed] [Google Scholar]

42. Eussen SJPM, de Groot LCPGM, Clarke R, et al. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial. Arch Intern Med. 2005;165:1167–1172. [PubMed] [Google Scholar]

43. Carmel R, Sarrai M. Diagnosis and management of clinical and subclinical cobalamin deficiency: advances and controversies. Curr Hematol Rep. 2006;5:23–33. [PubMed] [Google Scholar]

44. NAPS document 04827, supplement to Lederle FA. Oral cobalamin for pernicious anemia: medicine's best kept secret? JAMA. 1991;265:94–95. [PubMed] [Google Scholar]

45. Kokkola A, Sjoblom S-M, Haapiainen R, Sipponen P, Pulakkainen P, Jarvinen H. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. Scand J Gastroenterol. 1998;33:88–92. [PubMed] [Google Scholar]

46. Carmel R, Spencer CA. Clinical and subclinical thyroid disorders associated with pernicious anemia: observations on abnormal thyroid-stimulating hormone levels and on a possible association of blood group O with hyperthyroidism. Arch Intern Med. 1982;142:1465–1469. [PubMed] [Google Scholar]

47. Glasbrenner B, Malfertheiner P, Buchler M, Kuhn K, Ditschuneit H. Vitamin B12 and folic acid deficiency in chronic pancreatitis: a relevant disorder?. Klin Wochenschr. 1991;69:168–172. [PubMed] [Google Scholar]

48. Rhode BM, Tamim H, Gilfix BM, Sampalis JS, Nohr C, MacLean LD. Treatment of vitamin B12 deficiency after gastric surgery for severe obesity. Obes Surg. 1995;5:154–158. [PubMed] [Google Scholar]

49. Carmel R, Aurangzeb I, Qian D. Associations of food-bound cobalamin malabsorption with ethnic origin, age, Helicobacter pylori infection, and serum markers of gastritis. Am J Gastroenterol. 2001;96:63–70. [PubMed] [Google Scholar]

50. Dierkes J, Ebert M, Malfertheiner P, Luley C. Helicobacter pylori infection, vitamin B12 and homocysteine: a review. Dig Dis. 2003;21:237–244. [PubMed] [Google Scholar]

51. Lawhorne L, Ringdahl D. Cyanocobalamin injections for patients without documented deficiency: reasons for administration and patient responses to proposed discontinuation. JAMA. 1989;261:1920–1923. [PubMed] [Google Scholar]

52. Carmel R, Green R, Rosenblatt DS, Watkins D. Update on cobalamin, folate, and homocysteine. Hematology. 2003:62–81. [PubMed] [Google Scholar]

53. Carmel R, Karnaze DS. The deoxyuridine suppression test identifies subtle cobalamin deficiency in patients without typical megaloblastic anemia. JAMA. 1985;253:1284–1287. [PubMed] [Google Scholar]

54. Carmel R. Current concepts in cobalamin deficiency. Annu Rev Med. 2000;51:357–375. [PubMed] [Google Scholar]

55. Karnaze DS, Carmel R. Neurological and evoked potential abnormalities in subtle cobalamin deficiency states, including those without anemia and with normal absorption of free cobalamin. Arch Neurol. 1990;47:l008–1012. [PubMed] [Google Scholar]

56. Carmel R, Gott PS, Waters CH, et al. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol. 1995;54:245–253. [PubMed] [Google Scholar]

57. Hanger HC, Sainsbury R, Gilchrist NL, Beard ME, Duncan JM. A community study of vitamin B12 and folate levels in the elderly. J Am Geriatr Soc. 1991;39:1155–1159. [PubMed] [Google Scholar]

58. Howard JM, Azen C, Jacobsen DW, Green R, Carmel R. Dietary intake of cobalamin in elderly people who have abnormal serum cobalamin, methylmalonic acid and homocysteine levels. Eur J Clin Nutr. 1998;52:582–587. [PubMed] [Google Scholar]

59. van Asselt DZB, de Groot LCPGM, van Staveren WA, et al. Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr. 1998;68:328–334. [PubMed] [Google Scholar]

60. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med. 1996;156:1097–1100. [PubMed] [Google Scholar]

61. Hughes D, Elwood PC, Shinton NK, Wrighton RJ. Clinical trial of the effect of vitamin B12 in elderly subjects with low serum B12 levels. Br Med J. 1970;2:458–460.[PMC free article] [PubMed] [Google Scholar]

62. Waters WE, Withey JL, Kilpatrick GS, Wood PH. Serum vitamin B12 concentrations in the general population: a ten-year follow-up. Br J Haematol. 1971;20:521–526. [PubMed] [Google Scholar]

63. Elwood PC, Shinton NK, Wilson CI, Sweetnam P, Frazer EC. Haemoglobin, vitamin B12 and folate levels in the elderly. Br J Haematol. 1971;21:557–563. [PubMed] [Google Scholar]

64. Hvas AM, Ellegaard J, Nexo E. Increased plasma methylmalonic acid level does not predict clinical manifestations of vitamin B12 deficiency. Arch Intern Med. 2001;161:1534–1541. [PubMed] [Google Scholar]

65. Solomon LR. Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testing. Blood. 2005;105:978–985. [PubMed] [Google Scholar]

66. Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol. 1990;34:99–107. [PubMed] [Google Scholar]

67. Carmel R. Mild transcobalamin I (haptocorrin) deficiency and low serum cobalamin concentrations. Clin Chem. 2003;49:1367–1374. [PubMed] [Google Scholar]

68. Centers for Disease Control and Prevention. Neurologic impairment in children associated with maternal dietary deficiency of cobalamin—Georgia 2001. MMWR. 2003;52:61–64. [PubMed] [Google Scholar]

69. Schilling RF. Is nitrous oxide a dangerous anesthetic for vitamin B12 deficient subjects? JAMA. 1986;255:1605–1606. [PubMed] [Google Scholar]

70. Ng J, O'Grady G, Pettit T, Frith R. Nitrous oxide use in first-year students at Auckland University. Lancet. 2003;361:1349–1350. [PubMed] [Google Scholar]

71. Ng J, Frith R. Nanging. Lancet. 2002;360:384–385. [PubMed] [Google Scholar]

72. Clarke R, Sherliker P, Hin H, et al. Detection of vitamin B12 deficiency in older people by measuring vitamin B12 or the active fraction of vitamin B12, holotranscobalamin. Clin Chem. 2007;53:963–970. [PubMed] [Google Scholar]

Sours: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2532799/

Vitamin B12 deficiency

Summarytoggle arrow icon

Vitamin B12 (cobalamin) plays an essential role in enzymatic reactions responsible for red blood cell (RBC) formation and proper myelination of the nervous system. Thus, a deficiency of vitamin B12 may lead to megaloblastic anemia and a wide range of neurological disturbances. Deficiency may be caused by malabsorption, malnutrition, or increased demand. The most common underlying cause of vitamin B12 deficiency is pernicious anemia, an autoimmune disorder characterized by the absence of intrinsic factor (IF). IF is a protein that is crucial for vitamin B12 absorption. Patients present with signs of anemia (e.g., fatigue) and/or neurological manifestations such as paresthesia, spasticity, ataxia, and neuropsychiatric disorders. After detecting low serum vitamin B12 levels, the diagnostic approach consists of identifying the underlying cause by measuring autoantibodies and possibly conducting a Schilling test. When testing patients with suspected vitamin B12 deficiency, it is important to remember that folate deficiency also causes megaloblastic anemia. However, only vitamin B12 deficiency can be accompanied by neuropathy and exhibits elevated levels of methylmalonic acid (MMA). Treatment consists of parenteral supplementation; depending on the underlying cause, long-term supplementation may be needed.

Etiologytoggle arrow icon

Pathophysiologytoggle arrow icon

Dysfunctional biochemical reactions

Folate deficiency also leads to low levels of THF, resulting in megaloblastic anemia.

Pernicious anemia

Clinical featurestoggle arrow icon

  • Signs of anemia (e.g., fatigue, pallor)[3]
  • Mild scleral icterus and/or jaundice
  • Neurological disturbances are generally symmetrical
    • Peripheral neuropathy: tingling, numbness, pins-and-needles sensation, coldness (especially in the lower extremities)
    • Subacute combined degeneration of spinal cord: symmetricaldemyelination of the spinal cord tracts occurs in vitamin B12 deficiency due to insufficient vitamin B12-dependent fatty acid synthesis and production/maintenance of myelin
    • Neuropsychiatric disease; (e.g., reversible dementia, depression, paranoia) [3]
    • Worsening vision
    • Autonomic dysfunction: impotence and incontinence
  • Glossitis

The Spinocerebellar tracts, lateralCorticospinal tracts, and Dorsal columns are affected in Subacute Combined Degeneration.

Always consider vitamin B12 deficiency when evaluating patients with dementia.

Diagnosticstoggle arrow icon

Hematological findings

Approach

Differential diagnosestoggle arrow icon

Differential diagnoses of vitamin B12 deficiency

Differential diagnosis of vitamin B12, B9, and B1 deficiencies
Vitamin B12 deficiencyVitamin B9 deficiencyVitamin B1 deficiency
Syndrome
Causes
Motor signs
Sensory signs
  • Sensory deficit and paresthesias in distal parts of extremities ("socks and gloves" distribution)
  • Sensory deficit and paresthesias in distal parts of extremities ("socks and gloves" distribution)
Other neurological features
Neuropsychiatric signs
  • Confusion
  • Cognitive deficits
Diagnostics
Management
Prognosis
  • Potentially reversible (neurological damage may be permanent)

Starting folate treatment before excluding vitamin B12 deficiency may correct anemia, but it can worsen neuropathy!

In contrast to vitamin B12 deficiency, folic acid deficiency is generally not associated with neurological symptoms.

Other causes of macrocytic anemia

Other causes of neuropathy

The differential diagnoses listed here are not exhaustive.

Treatmenttoggle arrow icon

References:[6]

Referencestoggle arrow icon

  1. Vitamin B 12. http://www.msdmanuals.com/professional/nutritional-disorders/vitamin-deficiency,-dependency,-and-toxicity/vitamin-b-12. Updated: September 1, 2016. Accessed: December 21, 2016.
  2. Scalabrino G. Cobalamin (vitamin B(12)) in subacute combined degeneration and beyond: traditional interpretations and novel theories.. Exp Neurol. 2005; 192 (2): p.463-79. doi: 10.1016/j.expneurol.2004.12.020 . | Open in Read by QxMD
  3. Johnson LE. Vitamin B 12. undefined. 2016 .
  4. Mazokopakis EE. The old Schilling test as a necessary criterion at present for the diagnosis of food-cobalamin malabsorption (FCM) syndrome. Hell J Nucl Med. 2012; 15 (3): p.262-263.
  5. Ramphul K, Mejias SG. Schilling Test. StatPearls. 2020 .
  6. Guidelines for the Investigation & Management of vitamin B12 deficiency. http://www.ruh.nhs.uk/For_Clinicians/departments_ruh/Pathology/documents/haematology/B12_-_advice_on_investigation_management.pdf. Updated: January 3, 2017. Accessed: January 3, 2017.
Sours: https://www.amboss.com/us/knowledge/Vitamin_B12_deficiency/
  1. Island hills stables
  2. 1994 f150 radiator
  3. Elliott crane trucks
  4. Nice torch lighter

How Much Vitamin B12 Is Too Much?

Vitamin B12 is a water-soluble nutrient that plays many critical roles in your body.

Some people think that taking high doses of B12 — rather than the recommended intake — is best for their health.

This practice has led many to wonder how much of this vitamin is too much.

This article examines the health benefits, as well as potential risks of taking megadoses of B12.

Benefits of Supplementing With Vitamin B12

There’s no question that vitamin B12 is essential for health.

This nutrient is responsible for numerous functions in your body, including red blood cell formation, energy production, DNA formation and nerve maintenance ().

Though B12 is found in many foods, such as meat, poultry, seafood, eggs, dairy products and fortified cereals, many people don’t get enough of this important vitamin.

Health conditions such as inflammatory bowel disease (IBD), certain medications, genetic mutations, age and dietary restrictions can all contribute to an increased need for B12.

Vitamin B12 deficiency can lead to serious complications such as nerve damage, anemia and fatigue, which is why those at risk should add a high-quality B12 supplement to their diet ().

While people who consume adequate amounts of B12-rich foods and are able to properly absorb and utilize this nutrient don’t necessarily need to supplement, taking extra B12 has been linked to some health benefits.

For example, studies show that supplemental B12 may benefit people without a deficiency in the following ways:

  • Improved mood: One study found that supplementing healthy men with a B-complex vitamin containing a high dose of B12 improved ratings of stress and enhanced performance on cognitive tests ().
  • Reduced symptoms of anxiety and depression: Treatment with a supplement containing a high dose of B12 for 60 days significantly improved depression and anxiety symptoms in adults when compared to a placebo ().

Although B12 supplements are commonly taken to boost energy levels, there is currently no evidence suggesting that more B12 increases energy in people with adequate levels of this vitamin.

However, B12 supplements will most likely increase energy levels in those who are deficient, as this nutrient plays an important role in converting food into energy.

Summary

B12 is an important nutrient that is essential for red blood cell formation, DNA synthesis and many other vital processes. Supplements may help boost mood and reduce symptoms of depression in those who are not deficient in this vitamin.

Is Taking High Doses of B12 Helpful or Harmful?

Since B12 is a water-soluble vitamin, it’s generally considered safe, even at high doses.

No Tolerable Upper Intake Level (UL) has been established for B12, due to its low level of toxicity. UL refers to the maximum daily dose of a vitamin unlikely to cause adverse side effects in the general population.

This threshold has not been set for B12 because your body excretes whatever it doesn’t use through your urine.

However, supplementing with excessively high levels of B12 has been linked to some negative side effects.

Several studies have shown that megadoses of the vitamin can lead to outbreaks of acne and rosacea, a skin condition that causes redness and pus-filled bumps on the face.

Yet, it should be noted that most of these studies focused on high-dose injections rather than oral supplements (, 6, ).

There is also some evidence suggesting that high doses of B12 may lead to negative health outcomes in those with diabetes or kidney disease.

One study found that people with diabetic nephropathy (loss of kidney function due to diabetes) experienced a more rapid decline in kidney function when supplemented with high-dose B vitamins, including 1 mg per day of B12.

What’s more, the participants receiving the high-dose B vitamins had a greater risk of heart attack, stroke and death, compared to those receiving a placebo ().

Another study in pregnant women showed that extremely high B12 levels due to vitamin supplements increased the risk of autism spectrum disorder in their offspring ().

Though there is evidence that supplementing with B12 may cause negative health outcomes, studies have demonstrated that daily oral supplements of up to 2 mg (2,000 mcg) are safe and effective in treating B12 deficiency ().

For reference, the recommended daily intake (RDI) of vitamin B12 is 2.4 mcg for both men and women, though pregnant and breastfeeding women have a higher need ().

Summary

Although there is some evidence that very high doses of B12 may cause adverse health effects in certain populations, megadoses of this vitamin are commonly used to safely and effectively treat B12 deficiency.

How Much B12 Should You Take?

For healthy individuals who are not at risk for B12 deficiency, eating a well-rounded, healthy diet should provide all the B12 their body needs.

Food sources of this vitamin include eggs, red meat, poultry, seafood, milk, yogurt, fortified cereals, nutritional yeast and fortified non-dairy milks.

However, individuals on medications that impact B12 absorption, pregnant or breastfeeding women, vegans and anyone with a condition that negatively impacts the absorption of or increases the need for B12, should consider taking a supplement.

Additionally, evidence from population studies suggests that B12 deficiency in older adults is common, which is why it’s recommended that adults over 50 take supplements ().

While megadoses of up to 2,000 mcg are considered safe in treating B12 deficiency, it’s always best to avoid excessive amounts of any vitamin, especially when it’s not needed.

Though daily high doses of B12 are unlikely to cause harm in most people, extremely high doses should be avoided unless prescribed by a healthcare professional.

If you think you may be deficient in B12, speak with your doctor, who can recommend an appropriate treatment based on your level of deficiency.

While no UL has been set for B12, your body’s ability to absorb the vitamin depends on how much it actually needs.

For example, it’s estimated that only 10 mcg of a 500-mcg B12 supplement is actually absorbed in people without a deficiency ().

For this reason, taking high doses of B12 does not benefit people without an increased need.

Summary

Although supplemental B12 is required for people with an increased need for this vitamin, it’s unnecessary for those without a deficiency to take high doses.

The Bottom Line

B12 is an important nutrient that is popularly used as a nutritional supplement, even by those without a B12 deficiency.

Though doses of up to 2,000 mcg of vitamin B12 are considered safe, it’s best to speak to a doctor to find out whether taking a supplement is necessary.

Most people can fill their B12 needs through a healthy diet. Some, such as older adults or those with certain dietary restrictions, should supplement.

Sours: https://www.healthline.com/nutrition/too-much-vitamin-b12
Vitamin B12 ( Cobalamin ) Biochemistry / Properties , Deficiency , Sources , Toxicity

.

B12 uptodate vitamin toxicity

.

VITAMIN B12 explained – are you taking too much? (Flaw in WFPB diet?)

.

Now discussing:

.



1685 1686 1687 1688 1689